# Taisho Pharmaceutical Co., Ltd. – FDA Inspection, Mar 29, 2019

Source: https://www.keypedia.com/records/fda_inspections/taisho-pharmaceutical-co-ltd/e275948c-3022-4694-b50c-d1883d341100
Source feed: FDA_Inspections

> FDA inspection 1087840 of Taisho Pharmaceutical Co., Ltd., March 29, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087840
- Company Name: Taisho Pharmaceutical Co., Ltd.
- Inspection Date: 2019-03-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 951450 - 2015-11-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/rumany-c-penn/021eb1e0-8de0-403f-9596-3e76624b2e5a)

Company: https://www.keypedia.com/companies/taisho-pharmaceutical-co-ltd/290158c7-6701-466a-98f3-d39da84d4805

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c